Michael Leisch

486 total citations
14 papers, 273 citations indexed

About

Michael Leisch is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Michael Leisch has authored 14 papers receiving a total of 273 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Genetics, 6 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Michael Leisch's work include Acute Myeloid Leukemia Research (4 papers), CAR-T cell therapy research (3 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers). Michael Leisch is often cited by papers focused on Acute Myeloid Leukemia Research (4 papers), CAR-T cell therapy research (3 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers). Michael Leisch collaborates with scholars based in Austria, Germany and Slovakia. Michael Leisch's co-authors include Richard Greil, Lisa Pleyer, Alexander Egle, Nadja Zaborsky, Angela Risch, Roland Geisberger, Thomas Melchardt, Florian Huemer, Gabriel Rinnerthaler and Clemens Hufnagl and has published in prestigious journals such as Blood, Clinical Cancer Research and International Journal of Molecular Sciences.

In The Last Decade

Michael Leisch

13 papers receiving 268 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Leisch Austria 9 115 78 72 56 55 14 273
Youwen Qin China 11 197 1.7× 118 1.5× 61 0.8× 64 1.1× 35 0.6× 25 344
Xiongpeng Zhu China 9 207 1.8× 128 1.6× 73 1.0× 38 0.7× 48 0.9× 24 345
M. Georget France 5 78 0.7× 74 0.9× 78 1.1× 22 0.4× 53 1.0× 6 287
Guifang Ouyang China 10 152 1.3× 68 0.9× 63 0.9× 76 1.4× 46 0.8× 42 276
Katalin Csermak Switzerland 5 157 1.4× 96 1.2× 57 0.8× 16 0.3× 65 1.2× 6 324
A. Keith Stewart United States 10 205 1.8× 134 1.7× 132 1.8× 38 0.7× 60 1.1× 17 419
Toshie Ogasawara Japan 8 114 1.0× 128 1.6× 73 1.0× 15 0.3× 47 0.9× 25 280
YH Kuo Taiwan 6 234 2.0× 152 1.9× 51 0.7× 114 2.0× 98 1.8× 17 496
Janet C. Reid Australia 9 189 1.6× 36 0.5× 62 0.9× 42 0.8× 34 0.6× 16 327
Alun Parsons Finland 10 174 1.5× 152 1.9× 53 0.7× 44 0.8× 41 0.7× 18 304

Countries citing papers authored by Michael Leisch

Since Specialization
Citations

This map shows the geographic impact of Michael Leisch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Leisch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Leisch more than expected).

Fields of papers citing papers by Michael Leisch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Leisch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Leisch. The network helps show where Michael Leisch may publish in the future.

Co-authorship network of co-authors of Michael Leisch

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Leisch. A scholar is included among the top collaborators of Michael Leisch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Leisch. Michael Leisch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Leisch, Michael, Ildikó Tóth, M Mayer, et al.. (2025). Momelotinib Is Effective in Treatment for VEXAS Syndrome: Two Cases Within the AGMT Austrian Myeloid Registry. European Journal Of Haematology. 115(3). 299–302. 1 indexed citations
2.
Leisch, Michael, Franz Josef Gassner, Nadja Zaborsky, et al.. (2023). Myeloid NGS Analyses of Paired Samples from Bone Marrow and Peripheral Blood Yield Concordant Results: A Prospective Cohort Analysis of the AGMT Study Group. Cancers. 15(8). 2305–2305. 12 indexed citations
3.
Rudzki, Jakob, Ulrich Jaeger, Dominik Wolf‎, et al.. (2022). Stringent Nationwide Selection Criteria for CAR-T Cell Therapy Ensure Favourable Outcome of Patients with LBCL - First Data from the Austrian CAR-T Network. Blood. 140(Supplement 1). 6661–6663.
4.
Huemer, Florian, Michael Leisch, Roland Geisberger, Nadja Zaborsky, & Richard Greil. (2021). miRNA-Based Therapeutics in the Era of Immune-Checkpoint Inhibitors. Pharmaceuticals. 14(2). 89–89. 13 indexed citations
5.
Leisch, Michael, Daniel Neureiter, Alexander Egle, et al.. (2021). Two Cases of Pancytopenia with Coombs-Negative Hemolytic Anemia after Chimeric Antigen Receptor T-Cell Therapy. International Journal of Molecular Sciences. 22(11). 5449–5449. 2 indexed citations
6.
Huemer, Florian, Michael Leisch, Roland Geisberger, et al.. (2020). Combination Strategies for Immune-Checkpoint Blockade and Response Prediction by Artificial Intelligence. International Journal of Molecular Sciences. 21(8). 2856–2856. 37 indexed citations
7.
Hufnagl, Clemens, Michael Leisch, Lukas Weiß, et al.. (2019). Evaluation of circulating cell‑free DNA as a molecular monitoring tool in patients with metastatic cancer. Oncology Letters. 19(2). 1551–1558. 13 indexed citations
8.
Leisch, Michael, et al.. (2019). Next Generation Sequencing in AML—On the Way to Becoming a New Standard for Treatment Initiation and/or Modulation?. Cancers. 11(2). 252–252. 45 indexed citations
9.
Asslaber, Daniela, Michael Leisch, Yuan Qi, et al.. (2018). BIRC3 Expression Predicts CLL Progression and Defines Treatment Sensitivity via Enhanced NF-κB Nuclear Translocation. Clinical Cancer Research. 25(6). 1901–1912. 32 indexed citations
10.
Leisch, Michael, Alexander Egle, & Richard Greil. (2018). Plitidepsin: A Potential New Treatment For Relapsed/Refractory Multiple Myeloma. Future Oncology. 15(2). 109–120. 43 indexed citations
11.
12.
13.
Leisch, Michael, Christof Jungbauer, Alexander Egle, et al.. (2017). Red blood cell alloimmunization in 184 patients with myeloid neoplasms treated with azacitidine – A retrospective single center experience. Leukemia Research. 59. 12–19. 11 indexed citations
14.
Edlinger, Christoph, Bernhard Wernly, Michael Leisch, et al.. (2016). Analysis of Ambient Influences Affecting Interleukin-6 Secretion in the Context of Clinical Trials of Stem Cell Therapy for Myocardial Infarction. Clinical Laboratory. 62(06/2016). 1061–8. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Youwen Qin Breakdown of academic impact, for papers by Xiongpeng Zhu Breakdown of academic impact, for papers by M. Georget Breakdown of academic impact, for papers by Guifang Ouyang Breakdown of academic impact, for papers by Katalin Csermak Breakdown of academic impact, for papers by A. Keith Stewart Breakdown of academic impact, for papers by Toshie Ogasawara Breakdown of academic impact, for papers by YH Kuo Breakdown of academic impact, for papers by Janet C. Reid Breakdown of academic impact, for papers by Alun Parsons
Rankless by CCL
2026